FRANKFURT, Feb 28 (Reuters) - German pharmaceutical company Merck KGAA said on Sunday it has entered into an agreement with Millipore to acquire all of Millipore's shares for $107 per share cash, valuing the deal at around $7.2 billion including net debt.
In a statement, Merck said the two companies would create a 2 billion euro entity for the life science sector.
'Due to the fact that the two businesses are highly complementary Merck expects that the transaction will clear regulatory review,' the statement said.
Merck expects the deal will be completed in the second half of 2010. Keywords: MERCKKGAA/MILLIPORE (Reporting by Marilyn Gerlach; Editing by Diane Craft; Reuters Messaging: marilyn.gerlach.reuters.com@reuters.net; 00 49 69 7565 1279) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
In a statement, Merck said the two companies would create a 2 billion euro entity for the life science sector.
'Due to the fact that the two businesses are highly complementary Merck expects that the transaction will clear regulatory review,' the statement said.
Merck expects the deal will be completed in the second half of 2010. Keywords: MERCKKGAA/MILLIPORE (Reporting by Marilyn Gerlach; Editing by Diane Craft; Reuters Messaging: marilyn.gerlach.reuters.com@reuters.net; 00 49 69 7565 1279) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.